has received honoraria from AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim-Lilly, Bristol-Myers Squibb, CSL-Behring, Gilead Sciences, Inc., Janssen, Lexicon Pharmaceuticals, Maze Therapeutics, Merck, Mitsubishi Tanabe, Novartis, Novo Nordisk, Otsuka, Prometic Pharma, Sanofi, and Youngene Therapeutics and has received operational funding for clinical trials from AstraZeneca, Boehringer Ingelheim-Lilly, CSL-Behring, Janssen, Merck, Novo Nordisk, and Sanofi
doi: 10.1007/s00125-018-4789-6 37 DruckerDJ
Recent advancements in metabolomics technology have revealed significant changes in microbial metabolites like short-chain fatty acid (SCFAs), tryptophan metabolites, bile acids, and phytoestrogens in MS
Our clinics in Irving, Texas focus exclusively on branded, FDA-approved medications
M., Hagele, A